Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Robert W. Holloway, MD
AdventHealth Cancer Institute
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
32 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of South Alabama, Mitchell Cancer Institute
Mobile, Alabama, United States
Jennifer Pierce, MDRecruiting - University of Arizona Cancer Center
Tucson, Arizona, United States
Setsuko K. Chambers, MDRecruiting - City of Hope
Duarte, California, United States
Edward Wang, MD, PhDRecruiting - Uc San Diego Health - Moores Cancer Center
La Jolla, California, United States
Michael McHale, MDRamez Eskander, MDRecruiting - Hoag Gynecologic Oncology
Newport Beach, California, United States
Alberto Mendivil, MDRecruiting - Uci Health Chao Family Comprehensive Cancer Center
Orange, California, United States
Krishnansu S. Tewari, MDRecruiting - Adventhealth Cancer Institute
Orlando, Florida, United States
Robert W Holloway, MDRecruiting - Sarasota Memorial Healthcare System
Sarasota, Florida, United States
Beverly Long, MDRecruiting - Women'S Cancer Associates With Women'S Care Florida
St. Petersburg, Florida, United States
Megan Indermaur, MDRecruiting - Emory University
Atlanta, Georgia, United States
Jennifer Scalici, MDRecruiting - Indiana University Simon Comprehensive Cancer Center
Indianapolis, Indiana, United States
Jessica E. Parker, MDRecruiting - Holy Cross Hospital
Silver Spring, Maryland, United States
Frederick D Min, MDJasmine Ebott, MDRecruiting - University of Michigan
Ann Arbor, Michigan, United States
Jean Siedel, MDRecruiting - Karmanos Cancer Institute
Detroit, Michigan, United States
Robert Morris, MDRecruiting - Mercy Hospital St. Louis
St Louis, Missouri, United States
Madhavi Manyam, MDRecruiting - Washington University School of Medicine
St Louis, Missouri, United States
Premal Thaker, MDRecruiting - Women'S Cancer Center of Nevada
Las Vegas, Nevada, United States
Nicola M. Spirtos, MDRecruiting - Center of Hope
Reno, Nevada, United States
Peter Lim, MDRecruiting - Stony Brook Cancer Center
Stony Brook, New York, United States
Gabrielle Gossner, MDRecruiting - Levine Cancer Institute
Charlotte, North Carolina, United States
Erin K Crane, MDRecruiting - East Carolina University
Greenville, North Carolina, United States
Grainger Lanneau, MDRecruiting - Cleveland Clinic
Cleveland, Ohio, United States
Peter Rose, MDRecruiting - Ohiohealth Research Institute
Columbus, Ohio, United States
Aine Clements, MDRecruiting - Kettering Health
Kettering, Ohio, United States
Thomas J. Reid, MDRecruiting - Promedica Flower Hospital
Sylvania, Ohio, United States
Adam Walter, MDRecruiting - Oklahoma University Health Stephenson Cancer Center
Oklahoma City, Oklahoma, United States
Debra Richardson, MDRecruiting - Ahn West Penn Hospital
Pittsburgh, Pennsylvania, United States
Sarah Crafton, MDRecruiting - Hollings Cancer Center
Charleston, South Carolina, United States
Brian Orr, MDRecruiting - Erlanger Health, Inc.
Chattanooga, Tennessee, United States
Stephen DePasquale, MDRecruiting - Baylor College of Medicine
Houston, Texas, United States
Jan Sunde, MDRecruiting - University of Texas Science Center at Houston, Mcgovern Medical School
Houston, Texas, United States
Joseph Lucci, III, MDRecruiting - Providence Sacred Heart Medical Center & Children'S Hospital
Spokane, Washington, United States
Melanie Bergman, MDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2022
- Primary completion
- 31 Dec 2026
- Completion
- 31 Dec 2027
- Last update posted
- 10 Jul 2026
- Registered enrollment
- 186
- Registry id
- NCT05281471
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.